Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Biomarkers & Precision Medicine 2025

30 September - 01 October 2025 | London, UK

Europe’s flagship event for biomarkers technological innovation returns: advancing biomarkers in drug discovery, development, clinical trials and accelerating precision medicine

Overview Biomarkers Spatial Biology For Precision Medicine Digital Pathology & AI

Explore Biomarkers & Precision Medicine 2025: Navigating Challenges Across the Biomarkers Value Chain to Propel Discovery through to Clinical Development


Join us for the 20th Annual Biomarkers & Precision Medicine Congress, an immersive event spotlighting the latest trends and tools in biomarker research. This year’s agenda also includes dedicated sessions on Spatial Biology for Precision Medicine and Digital Pathology & AI. The event gathers leading experts from global pharmaceutical companies, pioneering biotech firms & startups, and leading academic & healthcare institutions, all contributing to various therapeutic areas and stages of drug development, clinical trials, and precision patient treatments.

Download Agenda

Biomarkers UK 2025

  • 2-day programme to hear from and share insights with key innovators from pharma and healthcare in biomarkers discovery, development, translational research, precision medicine, clinical development and diagnostic strategies. 2024 attendees included: Director, AstraZeneca; Director, Novartis; Associate Director, UCB
  • New to 2025! Gain invaluable insights into the latest advancements in the integration of biomarkers in early drug development through unique case studies across multiple therapeutic areas. Key opinion leaders will be presenting on NASH, cardiovascular disease detection, rare & autoimmune diseases and oncology, immune-oncology & neuroscience    
  • New to 2025! Discovery collaborative solutions for digital transformation & digital biomarkers. Presentations will cover digital biomarkers for disease detection and monitoring; integration of digital health technologies & devices & accelerating the development of digital biomarkers & adoption
  • New to 2025! Discuss the latest innovations in navigating regulatory barriers in clinical trials & CdX and complex biomarkers. From in vitro diagnostics regulations and quality environment for quality testing through to how regulators can support the development and adoption
  • Engage in thought-provoking panel discussions, roundtables & workshops on the latest developments, emerging innovations & novel technologies in biomarkers discovery development. Discussion sessions include: ‘Biomarker Analysis Techniques’; ‘Patient-Centric Biomarkers In Clinical Trials’ and ‘Reflection When Biomarker Development Fails And Lessons Learnt in Pre-Clinical Development’

Agenda at a Glance

Day One

  • Track 1: Biomarkers Identification, Validation in Oncology, Immuno-Oncology & Immunology
  • Track 2: Enabling Precision Medicine for Diagnostics & Development
  • Track 3: Biomarkers for Clinical Development

Day Two

  • Track 1: Biomarkers Identification & Validation: Neuroscience & Co-Morbidity
  • Track 2: New & Emerging Biomarker Technologies for Biomarker Analysis  & Data Science
  • Track 3: Biomarkers for Clinical Trials
  • Track 4: Genomic & Multi-Omic Approaches in Biomarkers Discovery and Development
Download Agenda

Spatial Biology For Precision Medicine 2025

  • Hear from and meet with the key innovators in spatial biology. 2024 attendees include, Senior Vice President, Clinical & Translational Sciences; Associate Director, Image Analysis & Professor of Computational Genomics
  • Discuss the latest innovations in spatial multi omics techniques & approaches. Presentations will delve into translating spatial imaging techniques & approaches into the clinic, multi-modality processing and case studies from various spatial multi-omics
  • Take a deep dive into image analysis, AI-powered imaging, and utilising digital pathology for spatial biology. Key opinion leaders will be providing insights into label free imaging technologies, algorithm design for spatial data and relevant spatial parameters in different model systems
  • Gain comprehensive insights into utilising spatial biology in pharma. Hear about spatial research & spatial technologies in pharma R&D and also using the technology for diagnostics purposes & clinical development use cases
  • Join a series of workshops, roundtable and panel discussions. Interactive sessions will include ‘Addressing The Future Needs Of Spatial Omics’; ‘Moving Towards Clinical Trial Phases To Support Disease Diagnostics’ and many more

Agenda at a Glance

Day One

  • Track 5: Spatial Multi Omics Techniques & Approaches
  • Track 6: Spatial Biology in Pharma & Translational Drug Research

Day Two

  • Track 5: Image Analysis, AI Powered Imaging, & Digital Pathology for Spatial Biology
  • Track 6: Applications of Spatial Research & Technologies in Biology
Download Agenda

Digital Pathology & AI 2025

  • Hear from and meet with key innovators in Digital Pathology and AI. 2025 attendees will include - Senior Vice President, Worldwide Pathology; Senior Consultant, Pathology etc
  • Discuss the latest innovations in AI, Image Analysis and computational pathology approaches. Presentations will delve into how AI is being successfully integrated into workflows and its use through case studies in various therapeutic areas to provide an AI based precision medicine approach
  • New to 2025! Take a deep dive into the business case and ROI of digital pathology. Key opinion leaders will be providing insights into the lessons they have learned in the procurement, implementation and deployment in a multi-site environment
  • New to 2025! Gain comprehensive insights into utilising Digital pathology in pharma. Hear about the digitalization of toxicology and the use of algorithms to develop and implement tissue-based endpoints as well as detection and quantification of biomarkers and their use in stratifying patients to enable precision medicine
  • Join a series of workshops, roundtable and panel discussions. Interactive sessions will include ‘AI Ethics, image format standardization’ Digital Pathology from a pathologists perspective and many more

Agenda at a Glance

Day One

  • Track 7: Image Analysis & AI
  • Track 8: Digital Pathology Implementation, Strategy & Applications

Day Two

  • Track 7: Computational Pathology & AI
  • Track 8: Utilizing Digital Pathology & AI in Pharma Research
Download Agenda
25f1494b-ec1b-4180-820e-7721ad50e98f-2-5668375logo-UBS-logo-AW-RGB

The Oxford Global team were fantastic to work with and helped make the organisation and scheduling of my conference seamless. I was not able to attend in person however the team ensured that all my meetings were arranged online so I could still participate. The team ensured that these meetings ran smoothly and efficiently. The leads that I have generated from the conference are very exciting and I am sure I will be attending again in the future.


Alex Certoma
Corporate Analyst, Universal Biosensors

Sanofi

Very productive meeting with precisely the right vendors for biomarker research.

Global Head of Biomarkers
Sanofi

Canopy Biosciences

Always enjoyed exhibiting at Oxford Global conferences as they are well organised from initial interest to the day of the event itself. The committee ensure all scheduled 1-2-1 meetings are attended and will also re-schedule if necessary. Venues have been spacious, and the catering has been of excellent quality including the desserts!


Paru Oatey
Business Development Manager – Northern Europe, Canopy Biosciences® – A Bruker Company

Abzu

I liked the high scientific level of the event and the great organisation, which left enough time for networking and the exchange of ideas and thoughts outside the regular agenda.


Marco Salvatore
Head of Target & Biomarker Discovery, Abzu

Sanofi

Very well organised event. The format was very suitable and sending meeting requests through the app worked very effectively.


Precision Medicine Head
Sanofi

Sapient Bioanalytics

Biomarkers UK is one the best organized conferences that we have attended. Oxford Global was very focused on helping us make the most of the event, from coordinating multiple high-value meetings on our behalf to giving us tools like the Swapcard app to make networking simple and effective. They provided an engaging program and gave us a platform to meet with like-minded individuals who believe in the transformative impact of biomarkers and had real interest in our offerings.


Tanya Nguyen
Head of Scientific Operations, Sapient

ONO Pharma

The conference was well organised, covering a wide range of important scientific topics relating to biomarkers.


Clinical Science Director
Ono Pharma UK Ltd

What to Expect

1000

leading pharma, biotech, healthcare & academic delegates

30
hours of presentations, discussions & interactive content
12
hours of networking breaks, including speed networking & refreshments
200
hours of pre-arranged 1-2-1 meetings, facilitating business growth
What to Expect Engaging Thought Leadership-1
What to Expect Global Technological Showcase-1
What to Expect Networking Emphasis-1
What to Expect Innovative Poster Displays-1

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Experience over 250 dynamic interactive discussions, C-level debates, collaborative roundtables, and thought-provoking presentations & innovation showcases curated with insights from top industry leaders and experts to benchmark your research & development pipeline

  • Global Technological Showcase

    An international & dynamic exhibition showcasing cutting-edge technologies and services from premier providers in the scientific field

  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, personalised 1-2-1 meetings, a vibrant drinks reception, and informal gatherings to foster meaningful connections

  • Innovative Poster Displays & Awards Ceremony

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and start up companies

Key Themes for Biomarkers & Precision Medicine 2025

The 2025 programme will delve into the intricacies of navigating regulatory barriers in clinical trials, with a specific focus on companion diagnostics (CdX) and the complexities of biomarkers. Discussions will also revolve around the pivotal role of biomarkers in clinical development, exploring advancements in spatial tissue imaging and the integration of AI technologies in biomarker research. With precision medicine also at the forefront, key opinion leaders will examine how these innovations are shaping the landscape of healthcare and the future of personalized treatment approaches within clinical trials. 

Companies Represented Include

Biotech Innovation & Collaboration

Inspiring Tomorrow's Breakthroughs: Unleashing Innovation & Collaboration in Biomarkers Research & Development

Join engaging presentations featured in our innovation and collaboration track running on day 1, inspiring growth and creating space for collaboration opportunities for all who attend. The core attendee mix includes early-stage and emerging biotech or (academic) spinoff companies developing their own platforms or technologies with fewer than 30 employees.  

The Innovation & Collaboration track will be comprising of 10-minute presentations and focused panel discussion sessions, encouraging networking, facilitating collaborations & showcasing emerging innovations in biomarkers discovery & development.

Featuring Attendees from Biotech and/or (Academic) Spinoff Companies Interested In:  

  • Seeking collaboration partners with pharma and solution providers 
  • Discovering new investment opportunities with pharma 
  • Learning about the latest industry trends & challenges  
  • Keeping updated with new innovations and technology solutions 
  • Showcasing their company profile to a targeted and engaged audience

2025 Young Scientist Awards (YSA) for Best Poster Presentation

The Biomarkers Young Scientist Awards include the best poster presentation award and are intended to honour an outstanding individual performance for a scientific work by a PhD student, PostDoc or early career scientist. 

Please submit your poster presentation by no later than 20th December 2024 in the below category: 

  • Emerging Technologies  
  • Biomarkers in Therapeutics  
  • Biomarkers in Diagnostics  
  • Biomarkers in Clinical Trials & Precision Medicine  
  • Omics-Based Biomarker Discovery
  • Student (PhD), PostDoc or early career scientist under 35 years of age. Proof must be provided via an active student ID card or a copy of status
  • Applicants must be the first AND presenting author of the submitted paper and register for the meeting by 20th December 2024
  • ONLY ONE YSA submission per person will be accepted. If authors submit multiple abstracts for consideration for the YSA, only one abstract will be taken into consideration for the YSA

Applicants must follow the procedure as follows: 

  • Register and submit an abstract by 20th December 2024 using the registration link to the left on this page 
  • Once registered you will be provided with the online abstract submission form 
  • Prepare the poster or platform and present it (The poster presenter should be at the poster during all breaks.) 
  • The 3 winners with the highest scores will be announced at the Networking Drinks on the second day of the event 
  • The winners’ 10-minute oral presentations will take place during the networking drinks on day 2 

The platform or poster presentation will be evaluated by senior scientists (consisting of our speaking and steering group committee for the Biomarkers series) on the basis of originality of the approach and quality of the work (e.g. appropriate methodology, interpretation of results, conclusiveness). All participants will receive the scoring and comments after the annual meeting via email.

The 3 winners receiving the highest scores will be announced at the Networking Drinks on the Day 2 and will be given a trophy as well as £1,000 contribution towards travel costs. Oxford Global will also provide winners with PLUS Pass – 12 months access to our content platform providing access to on-demand presentations, exclusive reports and highlights. 

For further information contact help@oxfordglobal.com

Meet Our Expert Speakers

Biomarkers & Precision Medicine 2025 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Below are some of our featured speakers:

Belinda Nedjai
Associate Professor,
Queen Mary University of London
Debayan Mukherjee
Principal Scientist,
GSK
Dmitri Mikhailov
Director,
Novartis
Donna Finch
Head of Translational and Clinical Science,
Alchemab Therapeutics
Jimmy Bell
Professor,
University of Westminster

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

Group Identify Prognostic Biomarker for SCLC and Treatment Using Chemotherapy

SCLC patients that express the gene PCDHB4 have a higher likelihood of developing a resistance to chemotherapy.
Read More

Proteomic Analysis of Serum Extracellular Vesicles Reveals Potential Biomarkers for Neuroblastoma

The proteomic analysis of extracellular vesicles is shaping up to be a promising biomarker discovery technique for diseases like neuroblastoma.
Read More

Blood Biomarkers Signal Increased Risk of Alzheimer's & MND After Multiple Rugby Concussions

Results that show rugby players that have sustained multiple concussions present with markers of neurodegenerative disease development.
Read More

Life Science Players Join €23m European Project for Precision Medicine, PRECISEU

The project will bring together life science institutions across European nations in the interest of expanding development of and access to advanced therapy medicinal products.
Read More

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Read More

Feinstein Institutes Links Blood Biomarkers to Psychosis in Alzheimer's Patients

The global aging population means that rates of Alzheimer's disease are expected to reach 14 million patients by 2060, many of whom will experience psychosis.
Read More

Plan Your Visit

Full details regarding accommodation, travel directions, health and safety, and other logistical information for the event will be added here in the coming months.

Register Your Interest

Submit your details and a member of our team will be in touch